Results 231 to 240 of about 254,812 (307)

Cross‐border reciprocal bartering in public–private tetradic networks

Decision Sciences, EarlyView.
Abstract Under the background of semiconductor and vaccine shortages during COVID‐19‐driven supply chain disruptions, this article adopts a multimethodological approach to investigate strategic solutions for cross‐border scarce goods bartering in a public–private (P–P) tetradic reciprocal network, which involves two pairs of P–P collaborative dyads ...
Jiuh‐Biing Sheu, Tsan‐Ming Choi, Thomas Y. Choi   +2 more
wiley   +1 more source

Availability of consistent, reliable, and actionable public data on US hospital administrative expenses. [PDF]

Health Aff Sch
Sahni NR, Istvan B, Bello Thornhill H, Joynt-Maddox KE, Cutler D, Emanuel EJ.   +5 more
europepmc   +1 more source

Improving Access to Necessary Oral Healthcare Among Racialized Women Impacted by Intimate Partner Violence: A Qualitative Exploration of Care Seeking Experiences

Dental Traumatology, EarlyView.
ABSTRACT Background/Aim Women with lived experiences of intimate partner violence (IPV), especially physical trauma to the head, neck, and face, can experience oral health issues, leading to significant dental problems. Despite these severe dental outcomes, racialized women who have experienced IPV often find oral healthcare largely inaccessible.
Cyndirela Chadambuka, Isabel Arruda‐Caycho, Clara Juando‐Prats, Amaya Perez‐Brumer, Tina Meisami, Carlos Quiñonez, Margaret Powell, Sonica Singhal, Matt Ratto, Ghazal Haddadi, Rulani Chauke, Patricia O'Campo, Beverley M. Essue   +12 more
wiley   +1 more source

Dealing with heavy menstrual bleeding in very rare bleeding disorders: from a patient's perspective. [PDF]

Res Pract Thromb Haemost
Raheja P, Abdul-Kadir R, Søndergaard Knudsen MJ, Burgess C, Schols SEM, Very Rare Coagulation Factor Deficiency Working Group and Women and Girls with Bleeding Disorders Working Group of European Association for Haemophilia and Allied Disorders (EAHAD).   +5 more
europepmc   +1 more source

Efficacy and Safety of Prophylaxis With a Plasma‐Derived von Willebrand Factor/Factor VIII Concentrate (Wilate) in Patients With Type 3 von Willebrand Disease—A WIL‐31 Study Sub‐Analysis

European Journal of Haematology, EarlyView.
ABSTRACT Objectives The WIL‐31 study demonstrated efficacy and safety of prophylaxis with the plasma‐derived von Willebrand factor/factor VIII concentrate wilate in von Willebrand disease (VWD) of all types and was the only prospective study with an on‐demand run‐in study as an intra‐individual comparator.
Claudia Djambas Khayat, Leonid Dubey, Adlette Inati, Toshko Lissitchkov, Dzmitry Novik, Elina Peteva, Robert F. Sidonio Jr, Ali T. Taher, Kateryna V. Vilchevska, Vladimir Vdovin, Ana Boban   +10 more
wiley   +1 more source

Subacute Appendicitis Within a De Garengeot Hernia: A Rare Case and Management Considerations. [PDF]

Case Rep Surg
Rossi C, Rossi G, Proehl T.
europepmc   +1 more source

Advances and Challenges in the Multidisciplinary Treatment of Retroperitoneal Infantile Fibrosarcoma in Early Life

European Journal of Haematology, EarlyView.
ABSTRACT Background and Aims Retroperitoneal Infantile Fibrosarcoma (RIFS) is a rare, locally aggressive pediatric soft tissue tumor. Its retroperitoneal location poses challenges due to proximity and potential invasion of critical structures such as the inferior vena cava (IVC).
Gaia Brunetti, Angelo Zarfati, Giorgio Persano, Giuseppe Maria Milano, Ida Russo, Gian Luigi Natali, Rita Alaggio, Alessandro Crocoli, Chiara Grimaldi   +8 more
wiley   +1 more source

Trajectories of Well-Being and Burnout Among Health and Social Services Community Workers During the COVID-19 Pandemic: A Longitudinal Study of Job Demands and Resources. [PDF]

J Community Psychol
Paquin A, Giroux A, Radziszewski S, Lauzier-Jobin F, Coulombe S, Houle J, Meunier S.   +6 more
europepmc   +1 more source

The Development and Progress of Health Information Technology in Iran. [PDF]

Health Sci Rep
Balaghafari A, Siamian H.
europepmc   +1 more source

Utility of Progression Rate Since Symptom Onset in Predicting Subsequent Survival in Progressive Supranuclear Palsy. [PDF]

Mov Disord
Xie T, Golbe LI.
europepmc   +1 more source